Associations of HIV pre-exposure prophylaxis (PrEP) indication, HIV risk perception and unwillingness to use PrEP among people who inject drugs in Baltimore, MD
Tarfa Verinumbe(Albert Einstein College of Medicine), Oluwaseun Falade‐Nwulia(Johns Hopkins University), Gregory M. Lucas(Johns Hopkins University), Miles Landry(Johns Hopkins University), Katie Zook(Johns Hopkins University), Kathleen R. Page(Johns Hopkins University), Brian W. Weir(Johns Hopkins University), Susan G. Sherman(Johns Hopkins University)
Cited by 4
Related Papers
Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection
|Clinical Infectious Diseases|2018|728
Oral Direct-Acting Agent Therapy for Hepatitis C Virus Infection
|Annals of Internal Medicine|2017|694
End-Stage Renal Disease Among HIV-Infected Adults in North America
|Clinical Infectious Diseases|2014|172